Wine is one of the utmost popular drinks consumed worldwide. The escalating demand for wine, because of its unusual taste and health assistances is one of the key aspects boosting the growth of the global wine market. The global wine mar…
BMI View: Pressure to increase premiums charged for Indonesia's universal healthcare scheme will remain
as it struggles with financial stability. Financial subsidies from the government to support the programme
will alleviate but not fully address the challenge, due to fiscal constraints. Such shifts to the country's
healthcare insurance programme will have influence the opportunities of healthcare providers and
drugmakers as it serves as a key driver of patient volume growth and medicine sales, respectively.
Headline Expenditure Projections
? Pharmaceuticals: IDR77.6trn (USD5.8bn) in 2015 to IDR85.6trn (USD6.3bn) in 2016; +10.2% growth
in local currency terms and +9.7% in US dollar terms.
? Healthcare: IDR330trn (USD24.6bn) in 2015 to IDR367trn (USD27bn) in 2016; +11.2% growth in local
currency terms and +10.7% in US dollar terms. Forecast revised upwards after incorporating a
significant increase in the government healthcare budget. Currency fluctuations reinforced the change in
US dollar terms.